AYTU BioPharma, Inc. (AYTU) Dividend History

AYTU BioPharma, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of therapies for rare and specialty conditions. The company markets oral formulations of testosterone and other hormone-based treatments, aiming to address hormonal deficiencies and related health issues. Founded with a focus on innovation in hormone therapy, AYTU aims to expand its product offerings and pipeline to serve underserved patient populations.

7900 E. Union Avenue, Denver, CO, 80237
Phone: (720) 437-6580
Website: https://www.aytubio.com

Dividend History

AYTU BioPharma, Inc. currently does not pay dividends

Company News

  • The 73rd Emerging Growth Conference is scheduled for July 17-18, 2024, featuring presentations from various companies in the healthcare, technology, and energy sectors.

    GlobeNewswire Inc.
    Featured Companies: ASPI ATRA CLNN CVKD GDTC IQST LGMK XXII
  • Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results. Shapeways Hldgs posted an adjusted loss of $1.36 per share, versus market expectations for a loss of 95 cents per share. The company’s quarterly sales came in at $8.37 million versus estimates of $8.75 million. Shapeways shares fell 20.8% to $2.36 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) shares climbed 62.4% to $2.16 after the company reported third-quarter results. Chemomab Therapeutics Ltd. (NASDAQ: CMMB) shares jumped 55% to $0.9497 after the FDA granted CM-101 Fast Track designation for adult patients of primary sclerosing cholangitis (PSC), a fibrotic liver disease. Heron Therapeutics, Inc. (NASDAQ: HRTX) climbed 50.8% to $0.8143 after the company reported mixed third-quarter financial results and issued guidance. Kinnate Biopharma Inc. (NASDAQ: KNTE) rose 47.7% to $2.32. The company’s board of directors received a letter from Foresite Capital Management and OrbiMed Advisors indicating their intent to explore and evaluate a potential acquisition of the company. SciSparc Ltd. (NASDAQ: SPRC) gained 44.5% to $6.30. SciSparc said 'trial results indicated that SciSparc's proprietary SCI-110 provided a safe and effective solution for alleviating agitation in elderly Alzheimer's patients who participated.' Evelo Biosciences, Inc. (NASDAQ: EVLO) gained 36% to $0.47. Babcock & Wilcox Enterprises, Inc. (NYSE: BW) climbed 34.3% to $1.75. Solid Biosciences Inc. (NASDAQ: SLDB) shares rose 32.7% to $2.83. Solid Biosciences announced IND clearance by the FDA for duchenne muscular dystrophy gene therapy candidate SGT-003. MGO Global, Inc. (NASDAQ: MGOL) shares climbed 32.4% to $0.6566 after reporting a sharp rise in third-quarter sales. Beyond Air, Inc. (NASDAQ: XAIR) gained 28% to $1.7920. AST SpaceMobile, Inc. (NASDAQ: ASTS) rose 28% to $4.8262 following third-quarter results. Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) shares climbed 25.2% to $24.34 after the company reported a ...

    Benzinga
  • Best penny stocks to buy? 4 with news to watch this week The post Best Penny Stocks? 4 Hot Stocks With News This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: GWH HON SIRI SJ
  • ANI (ANIP) delivered earnings and revenue surprises of 244.12% and 28.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: ANIP
Page data last updated 07/23/2025 17:02:04 UTC